About LYSTEDA

Safety and Tolerability of LYSTEDA

You should not take LYSTEDA if you currently have or have ever had a blood clot, have been told you are at risk for having a blood clot, or are allergic to LYSTEDA or tranexamic acid.

LYSTEDA can cause serious side effects, including:

  • The risk of serious blood clots may be increased when LYSTEDA is taken with hormonal contraceptives, especially if you are taking higher than your normal dose of birth control, are overweight, or if you smoke cigarettes. Risk of serious blood clots may also be increased if you take LYSTEDA with medicines used to help your blood clot or some medicines used to treat leukemia. Be sure to tell your health care provider if you take any of these medicines.
  • Stop taking LYSTEDA if you experience any eye changes, and promptly report any eye problems to your healthcare professional.
  • If you have an allergic reaction (have shortness of breath and your throat feels tight), stop taking LYSTEDA and get medical help right away.

The most common side effects of LYSTEDA include:

  • Headaches
  • Sinus and nasal problems
  • Back pain
  • Pain in your abdomen
  • Pain in your muscles or joints
  • Anemia
  • Fatigue

Tell your healthcare professional if you have any side effects that bother you or do not go away.

These are not all of the possible side effects of LYSTEDA. For more information, ask your healthcare professional or pharmacist.

If you notice a change in your usual menstrual bleeding pattern that worries you, or your heavy bleeding continues, contact your healthcare professional right away. This may be a sign of a more serious condition.

Call your healthcare professional for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088. You may also report side effects to Ferring Pharmaceuticals, Inc. at 1-888-FERRING (1-888-337-7464)

LYSTEDA has been studied in a wide range of patients aged 18 to 49. Women who smoke, are over weight and had fibroids also participated in the clinical trials.

hr divider

Frequently Asked Questions »

image placeholder

Though nearly 2 in 3 women have talked to a healthcare professional about their heavy monthly bleeding, fewer than half of those discussed treatment options.†

†Findings from "Living with Heavy Menstrual Bleeding – A National Survey of 500 U.S. Women," conducted online in June 2010 by Harris Interactive Inc. on behalf of Ferring Pharmaceuticals Inc. Download the full Harris Interactive survey on Heavy Menstrual Bleeding.